The impact of national centralized drug procurement on health expenditures for lung cancer inpatients: A difference-in-differences analysis in a large tertiary hospital in China

The availability and affordability of medicines remain major health challenges around the world. In March 2019, the Chinese government introduced a pilot National Centralized Drug Procurement (NCDP) program in order to reduce drug prices and improve the affordability of effective and safe medicines....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuan-jin, Ren, Yan, Zheng, Quan, Tan, Jing, Yao, Ming-hong, Huang, Yun-xiang, Zhang, Xia, Zou, Kang, Zhao, Shao-yang, Sun, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412196/
https://www.ncbi.nlm.nih.gov/pubmed/36033763
http://dx.doi.org/10.3389/fpubh.2022.956823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412196/
https://www.ncbi.nlm.nih.gov/pubmed/36033763
http://dx.doi.org/10.3389/fpubh.2022.956823

Ejemplares similares